114 related articles for article (PubMed ID: 16796941)
1. [Gynecomastia by mirtazapin].
Navarro-González M; Alberdi-Leniz A; Gené-Badia J
Med Clin (Barc); 2006 Jun; 127(1):37-8. PubMed ID: 16796941
[No Abstract] [Full Text] [Related]
2. [Mirtazapin and gynecomastia-galactorrhea].
Schmutz JL; Barbaud A; Trechot P
Ann Dermatol Venereol; 2005 Feb; 132(2):195. PubMed ID: 15798581
[No Abstract] [Full Text] [Related]
3. [Gynecomastia-galactorrhea during treatment with mirtazapine].
Lynch A; Madjlessi A
Presse Med; 2004 Apr; 33(7):458. PubMed ID: 15105766
[No Abstract] [Full Text] [Related]
4. Mirtazapine-induced akathisia.
Gulsun M; Doruk A
J Clin Psychopharmacol; 2008 Aug; 28(4):467. PubMed ID: 18626283
[No Abstract] [Full Text] [Related]
5. [Edema tendency, dyspnea and hypertension in the treatment with mirtazapine (Remeron)].
Jensen JB
Ugeskr Laeger; 1999 May; 161(18):2699. PubMed ID: 10434798
[No Abstract] [Full Text] [Related]
6. Serotonin syndrome with mirtazapine-fluoxetine combination.
Benazzi F
Int J Geriatr Psychiatry; 1998 Jul; 13(7):495-6. PubMed ID: 9695042
[No Abstract] [Full Text] [Related]
7. Mirtazapine: a newer antidepressant.
Hartmann PM
Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of mirtazapine in clinically relevant subgroups of depressed patients.
Nutt DJ
Depress Anxiety; 1998; 7 Suppl 1():7-10. PubMed ID: 9597345
[TBL] [Abstract][Full Text] [Related]
9. The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England.
Biswas PN; Wilton LV; Shakir SA
J Psychopharmacol; 2003 Mar; 17(1):121-6. PubMed ID: 12680749
[TBL] [Abstract][Full Text] [Related]
10. Neutropenia associated with mirtazapine use: is a drop in the neutrophil count in a symptomatic older adults a cause for concern?
Ahmed A
J Am Geriatr Soc; 2002 Aug; 50(8):1461-3. PubMed ID: 12165012
[No Abstract] [Full Text] [Related]
11. Mirtazapine and bone marrow suppression: a case report.
Hutchison LC
J Am Geriatr Soc; 2001 Aug; 49(8):1129-30. PubMed ID: 11555082
[No Abstract] [Full Text] [Related]
12. Mirtazapine: unable to induce serotonin toxicity?
Gillman PK
Clin Neuropharmacol; 2003; 26(6):288-9; author reply 289-90. PubMed ID: 14646604
[No Abstract] [Full Text] [Related]
13. Understanding the clinical profile of a drug on the basis of its pharmacology: mirtazapine as an example.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2008 Dec; 46(12):19-23. PubMed ID: 19133491
[TBL] [Abstract][Full Text] [Related]
14. Adverse reactions to mirtazapine are unlikely to be serotonin toxicity.
Isbister GK; Whyte IM
Clin Neuropharmacol; 2003; 26(6):287-8; author reply 289-90. PubMed ID: 14646603
[No Abstract] [Full Text] [Related]
15. Mirtazapine-induced akathisia.
Girishchandra BG; Johnson L; Cresp RM; Orr KG
Med J Aust; 2002 Mar; 176(5):242. PubMed ID: 11999246
[No Abstract] [Full Text] [Related]
16. Mirtazapine withdrawal causing hypomania.
MacCall C; Callender J
Br J Psychiatry; 1999 Oct; 175():390. PubMed ID: 10789310
[No Abstract] [Full Text] [Related]
17. Lack of sexual adverse effects with mirtazapine.
Farah A
Am J Health Syst Pharm; 1998 Oct; 55(20):2195-6. PubMed ID: 9812164
[No Abstract] [Full Text] [Related]
18. Mirtazapine for treatment-resistant depression: a preliminary report.
Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
[TBL] [Abstract][Full Text] [Related]
19. Mirtazapine overdose with benign outcome.
Raja M; Azzoni A
Eur Psychiatry; 2002 Apr; 17(2):107. PubMed ID: 11973120
[No Abstract] [Full Text] [Related]
20. Peripheral edema associated with mirtazapine.
Kutscher EC; Lund BC; Hartman BA
Ann Pharmacother; 2001 Nov; 35(11):1494-5. PubMed ID: 11724109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
